These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2137365)
1. The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro. Geisinger KR; Berens ME; Duckett Y; Morgan TM; Kute TE; Welander CE Cancer; 1990 Mar; 65(5):1055-61. PubMed ID: 2137365 [TBL] [Abstract][Full Text] [Related]
2. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate. Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231 [TBL] [Abstract][Full Text] [Related]
3. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Osborne CK; Von Hoff DD; Mullins K Breast Cancer Res Treat; 1985; 6(3):229-35. PubMed ID: 2936413 [TBL] [Abstract][Full Text] [Related]
4. [Hormone dependence of malignant ovarian tumors--an in vitro model]. Schieder K; Bieglmayer C; Kölbl H Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477 [TBL] [Abstract][Full Text] [Related]
5. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results]. Sevelda P Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702 [TBL] [Abstract][Full Text] [Related]
6. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer. Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460 [TBL] [Abstract][Full Text] [Related]
7. Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer. Gundersen S; Kvinnsland S; Lundgren S; Klepp O; Lund E; Børmer O; Høst H Breast Cancer Res Treat; 1990 Nov; 17(1):45-50. PubMed ID: 2151369 [TBL] [Abstract][Full Text] [Related]
8. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients. Beltrán M; Alonso MC; Ojeda MB; Izquierdo A; Ferrer J; Picó C; Anglada L; Catalán G; Batiste-Alentorn E; Tusquets I Ann Oncol; 1991 Jul; 2(7):495-9. PubMed ID: 1832944 [TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma. Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642 [TBL] [Abstract][Full Text] [Related]
10. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. van den Berg HW; Martin J; Lynch M Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575 [TBL] [Abstract][Full Text] [Related]
11. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors. Iino Y; Ishikawa H; Izuo M; Takikawa H Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157 [TBL] [Abstract][Full Text] [Related]
12. Adriamycin action on human breast cancer cells: enhancement by medroxyprogesterone acetate. Shaikh NA; Owen AM; Ghilchik MW; Braunsberg H Int J Cancer; 1989 Apr; 43(4):733-6. PubMed ID: 2522913 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo. Kangas L; Grönroos M J Steroid Biochem; 1990 Jun; 36(3):253-7. PubMed ID: 2142248 [TBL] [Abstract][Full Text] [Related]
14. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. Nomura Y; Tashiro H; Takaeko F Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351 [TBL] [Abstract][Full Text] [Related]
15. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor. Wen L; Hong D; Yanyin W; Mingyue Z; Baohua L Arch Gynecol Obstet; 2013 May; 287(5):997-1004. PubMed ID: 23212665 [TBL] [Abstract][Full Text] [Related]
16. [Significance of the colony formation test in ovarian carcinoma]. Runge HM; Bücke W; Neumann HA Onkologie; 1984 May; 7 Suppl 2():66-73. PubMed ID: 6235468 [TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of lonidamine alone or combined with tamoxifen or medroxyprogesterone acetate in breast cancer cells. Sica G; Lama G; Iacopino F; Angelucći C; Della Cuna GR; Marchetti P Anticancer Res; 1991; 11(6):2099-102. PubMed ID: 1776846 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer. Mouridsen HT; Palshof T; Rose C Recent Results Cancer Res; 1980; 71():169-77. PubMed ID: 6988913 [TBL] [Abstract][Full Text] [Related]
19. Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma. Riippa P; Kauppila A; Sundström H; Vihko R Anticancer Res; 1984; 4(3):109-12. PubMed ID: 6235770 [TBL] [Abstract][Full Text] [Related]
20. Direct antiproliferative effect of triptorelin on human breast cancer cells. Marini L; Iacopino F; Schinzari G; Robustelli della Cuna FS; Mantovani G; Sica G Anticancer Res; 1994; 14(5A):1881-5. PubMed ID: 7847821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]